EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

 ISSN 2394-3211

Impact Factor: 7.065

 ICV - 79.57

Abstract

25 YEARS EXPERIENCE OF CLINICOPATHOLOGICAL PROFILE OF OVARIAN GERM CELL TUMORS IN INDIAN WOMEN AND THE UTILITY OF SALL4 AND OCT3/4 AS A DIAGNOSTIC IMMUNOHISTOCHEMICAL MARKER

Deepshikha Arora, *Ruchi Rathore M. D., Sonal Sharma M. D. and Sarla Agarwal M.D

ABSTRACT

Introduction: Ovarian germ cell tumors (GCT) differ from other ovarian tumors in their histology, age of presentation, prognosis and treatment. Complete knowledge of the Clinicopathological profile of these tumors and proper diagnosis of these neoplasms is essential for appropriate treatment and maintenance of fertility wherever possible. Material and Methods: This is a retrospective study of clinicopathologic profile of all the GCT of ovary received over a period of 25 years. The immunostaining characteristics of two immunohistochemical markers OCT3/4 and SALL4 were studied on 32 cases of malignant GCTs and their sensitivity and specificity for malignant GCTs were compared. Results: 25.7% (284/1102) of all the ovarian tumors were GCTs. Mature cystic teratoma was the most common tumor in our study forming 20.2% of the total ovarian neoplasms. Oct 3/4 displayed 100 percent positivity in dysgerminomas and mixed tumors with dysgerminomatous component but was largely negative in yolk sac tumors and was only focally positive in immature teratomas. SALL4 immunostain results were similar to OCT3/4 in dygerminomas, mixed GCTs and immature teratomas but SALL4 was found to be a far better marker for yolk sac tumors displaying 100 percent positivity with strong intensity. Conclusion: 25.7% (284/1102) of all the ovarian tumors were GCTs in our study. The present study indicates that SALL4 is a better marker than OCT3/4 for diagnosis of malignant GCTs and may fulfill the need for a pan germ cell marker.

Keywords: Germ cell tumor, OCT3/4, SALL4, dysgerminoma, ovary, immature teratoma, yolk sac tumor.


[Full Text Article] [Download Certificate]

Citation

  All Since 2019
 Citation  3086  2560
 h-index  18  17
 i10-index  64  44

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 November 2024 Issue has been Published, Kindly check it on https://www.ejpmr.com/issue

  • EJPMR: NOVEMBER ISSUE PUBLISHED

    NOVEMBER 2024 issue has been successfully launched on NOVEMBER 2024.

  • EJPMR New Impact Factor

    EJPMR Impact Factor has been Increased to 7.065 for Year 2024.

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database Academia

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along witcertificate to promote resear activity of scholar.

Best Article of current issue :

Dr. Kartik Neog
Download Article : Click here